trending Market Intelligence /marketintelligence/en/news-insights/trending/n_m5fk9_zmktpeaxkabmrw2 content esgSubNav
In This List

Allena Pharmaceuticals appoints director

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Allena Pharmaceuticals appoints director

Allena Pharmaceuticals Inc. appointed Andrew Hack to the board.

Hack was earlier nominated to replace Stephen Kraus on the company's board. He currently serves as the CFO of Editas Medicine Inc.

Newton, Mass.-based Allena Pharmaceuticals develops oral enzyme therapeutics to treat rare and severe metabolic and kidney disorders.